These data demonstrate that tolerance can be induced by vaginal Ag exposure
. In these experiments, mice were given vaginal agarose gel suppositories c
ontaining either 5 mg OVA or saline for 6 h, Mice were given suppositories
either during the estrous (estrogen dominant) or diestrous (progesterone do
minant) stage of the estrous cycle. Mice were restrained during the inocula
tion period to prevent orovaginal transmission of the Ag, After 1 wk, mice
were immunized s.c. with OVA in CFA. After 3 wk, mice were tested for delay
ed-type hypersensitivity responses by measuring footpad swelling and measur
ing in vitro proliferation of lymphocytes to Ag, Using ELISA, the magnitude
of the serum Ab response was also measured. In some mice, FITC conjugated
to OVA was used to track the dissemination of the protein into the systemic
tissues. The magnitude of footpad swelling was significantly reduced in mi
ce receiving OVA-containing suppositories during estrus compared with mice
receiving saline suppositories. Concomitant decreases in the Ag-specific pr
oliferative response were also observed in lymph node lymphocytes and splen
ocytes. Conversely, mice inoculated during diestrus did not show a decrease
d response to Ag by either footpad response or in vitro proliferation, Seru
m Ab titers in the estrus-inoculated mice did not decrease significantly. T
hese data demonstrate that the reproductive tract can be an inductive site
for mucosally induced tolerance. However, unlike other mucosal sites such a
s the lung and gastrointestinal tract, reproductive tract tolerance inducti
on is hormonally regulated.